Public Workshop: FDA/FTC Workshop on a Competitive Marketplace for Biosimilars - 03/09/2020 - 03/09/2020
The purpose of the public workshop is to discuss FDA and FTC ’s collaborative efforts to support appropriate adoption of biosimilars, discourage false or misleading statements about biosimilars, and deter anticompetitive behaviors in the biologic marketplace.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Drugs & Pharmacology | Workshops